Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-6-28
pubmed:abstractText
Loss of the fragile histidine triad (Fhit) protein has been documented in cervical cancer and dysplasia. The goal of this study was to confirm the utility of homozygous deletions, aberrant methylation, and immunohistochemical evaluations of FHIT as functionally relevant determinants of FHIT expression.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1071-5576
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
329-37
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15219888-Acid Anhydride Hydrolases, pubmed-meshheading:15219888-Base Sequence, pubmed-meshheading:15219888-Biological Markers, pubmed-meshheading:15219888-Cell Line, Tumor, pubmed-meshheading:15219888-Chromosome Mapping, pubmed-meshheading:15219888-Chromosomes, Human, Pair 3, pubmed-meshheading:15219888-DNA Methylation, pubmed-meshheading:15219888-Dinucleoside Phosphates, pubmed-meshheading:15219888-Female, pubmed-meshheading:15219888-HeLa Cells, pubmed-meshheading:15219888-Humans, pubmed-meshheading:15219888-Neoplasm Proteins, pubmed-meshheading:15219888-Polymerase Chain Reaction, pubmed-meshheading:15219888-RNA, Messenger, pubmed-meshheading:15219888-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15219888-Sequence Deletion, pubmed-meshheading:15219888-Transcription, Genetic, pubmed-meshheading:15219888-Uterine Cervical Neoplasms
pubmed:year
2004
pubmed:articleTitle
Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
pubmed:affiliation
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't